Cargando…
Amiodarone/norepinephrine/tocilizumab: Inflammatory perimyocarditis, pulmonary intravascular coagulopathy following off-label use, and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035869/ http://dx.doi.org/10.1007/s40278-021-93831-x |
Ejemplares similares
-
Epinephrine/norepinephrine/tocilizumab: Lack of efficacy: case report
Publicado: (2021) -
Convalescent anti SARS-CoV-2 plasma/norepinephrine/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2021) -
Tocilizumab: Lack of efficacy following off-label use: case report
Publicado: (2022) -
Bivalirudin/norepinephrine: Lack of efficacy and off label use: case report
Publicado: (2021) -
Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)